Lured By Its Discovery Platform And Pipeline, Amgen Bids For Nuevolution

 
• By Sten Stovall
  
Fish
Amgen’s $166.8m Offer Backed By Nuevolution Board And Key Shareholders • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip